TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis.

Purpose: We previously reported a dose-finding and phase II trial of the TI-CE regimen (paclitaxel [T] plus ifosfamide [I] followed by high-dose carboplatin [C] plus etoposide [E] with stem-cell support) in germ cell tumor (GCT) patients predicted to have a poor prognosis with conventional-dose salv...

Descripción completa

Detalles Bibliográficos

Publicado en:	Journal of Clinical Oncology Vol. 28; no. 10; pp. 1706 - 1714
Autores principales:	Feldman DR, Sheinfeld J, Bajorin DF, Fischer P, Turkula S, Ishill N, Patil S, Bains M, Reich LM, Bosl GJ, Motzer RJ, Feldman, Darren R, Sheinfeld, Joel, Bajorin, Dean F, Fischer, Patricia, Turkula, Stefan, Ishill, Nicole, Patil, Sujata, Bains, Manjit, Reich, Lilian M
Formato:	research Journal Article
Publicado:	American Society of Clinical Oncology 4/1/2010
Acceso en línea:	Ver este registro en EBSCOhost